Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Selexis SA is a pioneering life sciences company specializing in mammalian cell line development for the biopharmaceutical industry. Their proprietary SUREtechnology Platform™ and KEEPER® and CHO-Mcell® technologies enable the rapid, stable, and cost-effective generation of high-performance cell lines for producing therapeutic proteins and vaccines. Acquired by JSR Corporation in 2017, Selexis is now an integral part of JSR Life Sciences, contributing significantly to the 'molecule-to-market' services offered by the group. They partner with biotech and pharmaceutical companies globally to accelerate the development and manufacturing of complex biologics.
The headquarters serves as the primary center for research and development, cell line development operations, global business development, and corporate administration.
The facility houses state-of-the-art laboratories equipped for advanced cell line engineering, development, and characterization, supporting their proprietary technology platforms.
The work culture at Selexis SA is characterized by scientific rigor, innovation, collaboration, and a strong focus on quality and customer success, reflecting both Swiss precision and the dynamic nature of the biotech industry.
Its location in the Geneva biotech cluster provides access to a rich talent pool, research collaborations, and proximity to many European pharmaceutical partners.
Selexis SA serves a global clientele from its base in Switzerland, with its reach and capabilities significantly amplified by being part of JSR Life Sciences. JSR Life Sciences supports functions globally, including business development, customer service, GMP manufacturing (through KBI Biopharma and other JSR entities), and strategic partnerships across North America, Europe, and Asia-Pacific. This network enables Selexis to offer its specialized cell line development services to pharmaceutical and biotech companies worldwide, facilitating seamless project integration from early development through to commercial manufacturing.
Chemin des Aulx 14
Plan-les-Ouates
Geneva
Switzerland
Address: Selexis SA primarily operates from its Geneva headquarters. Global reach and support are provided through JSR Life Sciences, which has significant operations in regions including North America (e.g., Sunnyvale, CA, USA; Research Triangle Park, NC, USA for KBI Biopharma) and Asia-Pacific (e.g., Tokyo, Japan; Shanghai, China).
To provide localized support, engage with regional clients, and integrate Selexis's expertise into JSR Life Sciences' comprehensive 'molecule-to-market' solutions for the global biopharmaceutical industry.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Selexis SA' leadership includes:
Selexis SA has been backed by several prominent investors over the years, including:
Publicly available information does not indicate significant executive hires or exits specifically at Selexis SA in the immediate last 12 months. Leadership changes within the broader JSR Life Sciences group may occur and indirectly impact Selexis SA. For example, Mark W. Womack transitioned from CEO of JSR Life Sciences to an advisory role in early 2024, with Tim Lowery appointed as his successor (effective April 2024), which is a change at the parent company level.
Discover the tools Selexis SA uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Selexis SA, as part of JSR Life Sciences, likely uses standardized professional email formats. The most common formats for companies of this nature are [first_initial][last]@[companydomain.com] or [first].[last]@[companydomain.com]. Given their integration, some communications might also originate from or be directed to jsrlifesciences.com email addresses.
[first_initial][last]@selexis.com (e.g., jsmith@selexis.com) or [first].[last]@selexis.com (e.g., john.smith@selexis.com)
Format
dlange@selexis.com
Example
80%
Success rate
JSR Life Sciences News • February 7, 2024
JSR Corporation announced that Tim Lowery will be appointed President and CEO of JSR Life Sciences, effective April 1, 2024. Mark Womack, current CEO, will transition to an advisory role. This leadership change affects the parent company of Selexis SA....more
Business Wire • September 13, 2023
Selexis SA, a JSR Life Sciences company, and GigaGen Inc., a subsidiary of Grifols, announced they have signed a service agreement. Selexis will leverage its SUREtechnology Platform™ to advance GigaGen's diverse pipeline of recombinant polyclonal antibody therapeutics....more
Selexis SA Press Release • May 9, 2023
Selexis SA and SpyBiotech Ltd announced they have entered into a service agreement to develop the cell line for SpyBiotech’s novel vaccine candidate targeting human cytomegalovirus (HCMV), based on SpyBiotech’s proprietary Hepatitis B surface antigen (HBsAg) virus-like particle (VLP) platform technology....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Selexis SA, are just a search away.